Nutrition Publication

The Economic Impact of Lower Protein Infant Formula for the Children of Overweight and Obese Mothers

Editor(s): Kevin Marsh, Jörgen Möller, Hasan Basarir, Panagiotis Orfanos and Patrick Detzel.

The global prevalence of obesity is rising rapidly, highlighting the importance of understanding risk factors related to the condition. Childhood obesity, which has itself become increasingly prevalent, is an important predictor of adulthood obesity. Studies suggest that the protein content consumed in infanthood is an important predictor of weight gain in childhood, which may contribute to higher body mass index (BMI). The current study used health economic modelling to predict the long-term clinical and economic outcomes in Mexico associated with lower protein infant formula (IpIF) compared to a currently-used formula. The model predicts that individuals who receive lpIF in infancy go on to have lower BMI levels throughout their lives, are less likely to be obese or develop obesity-related disease, live longer, incur fewer health system costs and have improved productivity. Simulation-based economic modelling suggests that the benefits seen in the short term, with the use of lpIF over a currently-used formula, could translate into considerable health and economic benefits in the long term.

Ref. Marsh K et al. The economic impact of lower protein infant formula for the children of overweight and obese mother. Nutrients 2016;8(18):1-13.